Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Mouse TIMP-1 Antibody, R&D Systems™

Rat Monoclonal Antibody has been used in 3 publications
Supplier: R&D Systems MAB9801500
This item is not returnable.
View return policy
Description
TIMP-1 Monoclonal specifically detects TIMP-1 in Mouse samples. It is validated for Western Blot.Specifications
TIMP-1 | |
Monoclonal | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
CLGI, Collagenase inhibitor, collagenase inhibitor), EPATIMP-1, EPO, erythroid potentiating activity, Erythroid-potentiating activity, Fibroblast collagenase inhibitor, FLJ90373, HCI, metalloproteinase inhibitor 1, TIMP metallopeptidase inhibitor 1, TIMP1, TIMPtissue inhibitor of metalloproteinase 1 (erythroid potentiating activity, Tissue inhibitor of metalloproteinases 1 | |
Rat | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
7076 | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG2a |
Western Blot | |
151624 | |
Western Blot 1 ug/mL | |
P12032 | |
TIMP1 | |
Mouse myeloma cell line NS0-derived recombinant mouse TIMP-1 Cys25-Arg205 Accession # P12032 | |
500 μg | |
Primary | |
Detects mouse TIMP-1 in direct ELISAs and Western blots. Shows 100% cross-reactivity with recombinant rat TIMP-1 and 20% cross-reactivity with recombinant human TIMP-1. | |
Mouse | |
Supernatant |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction